AI Adverse Event Prediction Using Continuous Multi-Instrument Data
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical monitoring technologies are inadequate for early detection of adverse events due to reliance on manual data entry, batch processing, and lack of continuous data aggregation from various medical instruments, leading to missed precursors and ineffective AI models.
Innovation Solution
A vertically integrated AI-driven system that continuously aggregates and analyzes data from multiple medical instruments using dongles and a cloud-based platform to generate real-time predictions of adverse events by combining vital and non-vital signs data.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If manual data entry and batch processing are used in EMRs, then system complexity is reduced and ease of operation is improved, but data aggregation continuity deteriorates and measurement precision worsens
Solution Approach 1:
The patent replaces manual data entry mechanisms with automated electronic data extraction systems. The system automatically pulls data from medical instruments via standardized protocols (HL7, FHIR) and feeds it into the EMR, eliminating the mechanical process of manual transcription while improving data continuity and precision.
Solution Approach 2:
The patent introduces an intermediary data aggregation layer between medical instruments and the EMR. This intermediary system continuously collects data from instruments and translates it into EMR-compatible formats, ensuring continuous data flow without requiring direct integration with every instrument or manual intervention.
2Stability of the object's composition
If batch processing is used in EMRs, then data processing load is reduced and system stability is improved, but detection speed of adverse event precursors deteriorates
Solution Approach 1:
The system performs preliminary data aggregation and pre-processing in the background before adverse events occur. By continuously collecting and analyzing data in advance, the system is ready to immediately detect and respond to precursors without disrupting the stable batch processing architecture.
Solution Approach 2:
The patent implements periodic data aggregation cycles that continuously monitor patient data at regular intervals. This periodic action maintains system stability while enabling timely detection of adverse event precursors through consistent, rhythmical data collection rather than one-time batch processing.
3Adaptability or versatility
If manually entered data is used in EMRs, then data entry flexibility is improved and ease of operation is enhanced, but measurement precision deteriorates due to transcription errors
Solution Approach 1:
The patent replaces manual data entry with automated electronic extraction systems that directly pull data from medical instruments. This substitution eliminates transcription errors while maintaining flexibility through configurable data selection and customization options in the system interface.
4Measurement precision
If continuous data aggregation from multiple medical instruments is implemented, then detection accuracy of adverse event precursors is improved, but device complexity increases
Solution Approach 1:
The patent creates a universal data aggregation platform that can interface with multiple types of medical instruments through standardized protocols. This multi-functional system handles various data sources (vital signs monitors, infusion pumps, beds) through a single unified architecture, reducing overall system complexity while maintaining comprehensive data collection capabilities.
Data Source
AI summary
Methods and systems of creating artificial intelligence processes for predicting adverse events in a patient are provided in which processed vital signs medical data are extracted from a server in communication with one or more vital signs monitors, and raw non-vital signs medical data are extracted from one or more medical instruments, including extracting auxiliary medical data which are not displayed by the medical instruments. The processed vital signs medical data and raw non-vital signs medical data are sent to a cloud-based artificial intelligence platform, which inputs the combined medical data into an AI-driven adverse event prediction model. The adverse event prediction model is continually and automatically fed the combined medical data. The adverse event prediction model identifies adverse event precursors and provides an assessment of a level of risk that a patient will experience an adverse event and a timeframe within which the adverse event is likely to occur.


